ArticleJournal of managed care & specialty pharmacy2019

Assessing the Value of Sarilumab Monotherapy for Adults with Moderately to Severely Active Rheumatoid Arthritis: A Cost-Effectiveness Analysis.

Melanie D Whittington et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.